序号 |
标题 |
次数 |
作者 |
发布时间 |
181 |
Azido-PEG10-CH2COOH |
4 |
wyh |
2024-12-20 |
182 |
Mal-amido-PEG8-Val-Gly(CAS号:2353409-54-6) |
3 |
WYQ |
2024-12-20 |
183 |
Alloc-Val-Ala-PAB-PNP(CAS号:1884578-27-1) |
3 |
WYQ |
2024-12-20 |
184 |
Sulfhydryl Reactive Liposomes,巯基反应脂质体 |
3 |
axc |
2024-12-20 |
185 |
cas:100462-73-5,diethyl 7-bromoheptylphosphonate,7-溴庚基二膦酸二乙酯 |
4 |
kx |
2024-12-20 |
186 |
Propargyl-PEG2-CH2COOH,丙炔基-二聚乙二醇-乙酸 |
3 |
wyh |
2024-12-20 |
187 |
Mal-amido-PEG8-val-gly-PAB-OH - CAS 2353409-52-4 |
4 |
zyl |
2024-12-20 |
188 |
DBCO-PEG4-Val-Ala-PAB-PNP,CAS号:2348405-93-4 |
4 |
WYQ |
2024-12-20 |
189 |
Metal Chelating Liposomes,金属螯合脂质体 |
2 |
axc |
2024-12-20 |
190 |
HS-PEG10-CH2CH2COOH,硫基十聚乙二醇丙酸 |
2 |
wyh |
2024-12-20 |
191 |
cas:1446282-24-1,[10-(Diethoxy-phosphoryl)-decyl]-phosphonic acid,抗体药物偶联物(ADC) |
4 |
kx |
2024-12-20 |
192 |
Folate Liposomes,叶酸脂质体 |
7 |
axc |
2024-12-20 |
193 |
MC-Val-Cit-Doxorubicin ,CAS号:159857-70-2 |
4 |
WYQ |
2024-12-20 |
194 |
alpha-GalNAc-TEG-Alkyne,丙-2-炔氧基乙氧基)乙氧基)乙氧基)-2-乙酰氨基-2脱氧-α-D-吡喃半乳糖苷 |
4 |
wyh |
2024-12-20 |
195 |
Azido-PEG4-Val-Ala-PAB的结构式 |
3 |
zyl |
2024-12-20 |
196 |
cas:5943-17-9,Tetraethyl heptane-1,7-diylbis(phosphonate), ADC试剂 |
2 |
kx |
2024-12-20 |
197 |
Fmoc-PEG2-Val-Cit-PAB-OH |
4 |
zyl |
2024-12-20 |
198 |
TCO-PEG3-CH2-aldehyde,环辛烯-三聚乙二醇-CH2-醛基 |
4 |
wyh |
2024-12-20 |
199 |
cas:59156-70-6,Di(N-succinimidyl)adipate,己二酸 1,6-二(2,5-二氧代-1-吡咯烷基)酯 |
4 |
kx |
2024-12-20 |
200 |
Boc-Val-Cit-PAB-PNP cas:870487-10-8 |
3 |
zyl |
2024-12-20 |
201 |
Endo-BCN-PEG4-Val-Cit-PAB-MMAF详细信息 |
4 |
WYQ |
2024-12-20 |
202 |
FMOC-N-甲基-三聚乙二醇-丙酸,Fmoc-N-methyl-PEG3-CH2CH2COOH |
5 |
wyh |
2024-12-20 |
203 |
cas:98627-69-1,1,3-Bis-aminooxy propane,1,3-双氨基氧基丙烷 |
4 |
kx |
2024-12-20 |
204 |
m-PEG7-CH2CH2COOH,1093647-41-6 |
5 |
wyh |
2024-12-20 |
205 |
NHS ester-PEG4-VC-PAB-PBD |
2 |
zyl |
2024-12-20 |
206 |
cas:894096-02-7,β-D-triacetylglucopyranosiduronyl methyl ester-phenol-β-Alanine, ADC试剂 |
2 |
kx |
2024-12-20 |
207 |
Alloc-Val-Ala-PAB(CAS号:1343407-91-9) |
4 |
WYQ |
2024-12-20 |
208 |
VH032-NH-CO-CH2-NHBoc,2010986-19-1 |
4 |
wyh |
2024-12-20 |
209 |
Alloc-Val-Ala-OH(CAS号:330970-70-2) |
6 |
WYQ |
2024-12-20 |
210 |
DBCO Reactive Liposomes,DBCO反应性脂质体 |
2 |
axc |
2024-12-20 |
211 |
1714123-51-9,Tetrazine-biotin,生物素标记四嗪 |
3 |
kx |
2024-12-20 |
212 |
MC-Val-Ala-OH(CAS号:1895916-22-9) |
5 |
WYQ |
2024-12-20 |
213 |
Carboxylic Acid Reactive Liposomes,羧酸反应性脂质体 |
4 |
axc |
2024-12-20 |
214 |
Tetrazine-C5-NHS, 四嗪-C5-N-羟基琥珀酰亚胺酯,抗体药物偶联物(ADC) |
10 |
kx |
2024-12-20 |
215 |
Mal-PEG8-Val-Cit-PAB-MMAE(CAS号:2353409-69-3) |
3 |
WYQ |
2024-12-20 |
216 |
Biotinylated Liposomes 生物素化脂质体 |
3 |
axc |
2024-12-20 |
217 |
Endo-BCN-PEG4-Val-Cit-PAB-MMAE(CAS号:2762519-08-2) |
2 |
WYQ |
2024-12-20 |
218 |
MC-VC-PAB-DMAE-Etoposide的介绍 |
4 |
zyl |
2024-12-20 |
219 |
DBCO-PEG4-Val-Cit-PAB-MMAE(CAS号:2129164-91-4) |
3 |
WYQ |
2024-12-20 |
220 |
Azide Reactive Liposomes 叠氮反应性脂质体 |
3 |
axc |
2024-12-20 |
221 |
Tetrazine-SS-NHS,四嗪-二硫键-羟基琥珀酰亚胺酯, ADC试剂 |
5 |
kx |
2024-12-20 |
222 |
Amine Reactive Liposomes 胺反应性脂质体 |
5 |
axc |
2024-12-20 |
223 |
BCN-PEG4-vc-PAB-MMAF的结构式 |
2 |
zyl |
2024-12-20 |
224 |
BCN-PEG3-Val-Cit-PFP Ester, CAS号:2353409-45-5 |
3 |
WYQ |
2024-12-20 |
225 |
Azido-PEG3-Val-Cit-PAB-PNP,CAS号:2055047-18-0 |
3 |
WYQ |
2024-12-20 |